Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
GSK's RSV vaccine meets main goal
GSK's RSV vaccine meets main goal when co-administered with shingles shot
British drugmaker GSK said on Wednesday its respiratory syncytial virus (RSV) vaccine, when given together with its shingles shot, met the main goal of a late-stage trial in adults over 50 years of age.
GSK Builds Combo Case for RSV, Shingles Shots With Phase III Data
If approved, the co-administration of Arexvy and Shingrix could provide a more convenient vaccination regimen for patients and potentially bolster GSK’s faltering sales for both vaccines.
GSK's Respiratory Syncytial Virus Vaccine Given Together With Shingles Shot Shows Non-Inferior Immune Response In Older Adults
GSK plc (NYSE:GSK) released topline data from the phase 3 trial in adults 50 years and older evaluating the immunogenicity, reactogenicity and safety of Arexvy (Respiratory Syncytial Virus Vaccine) when co-administered with Shingrix (Zoster Vaccine).
GSK's RSV, Shingles vaccines show on-par immune response in joint trial
(Reuters) -British drugmaker GSK said on Wednesday administration of its respiratory syncytial virus (RSV) vaccine and shingles shot together generated the same immune response in a late-stage trial as separate adminstration of the vaccines.
GSK touts co-administration data for RSV, shingles vaccines as narrowed CDC guidance threatens sales
In the study, co-administration of GSK's RSV vaccine Arexvy and shingles shot Shingrix elicited non-inferior immune responses compared with separate administration of the vaccines.
GSK pursues co-administration of RSV and shingles vaccines
GSK has revised its annual vaccine sales forecast following new guidance on RSV from the CDC. But new evidence offers new hope.
GSK's experimental herpes vaccine fails to meet main goal in trial
British drugmaker GSK said on Wednesday its experimental herpes simplex virus (HSV) vaccine candidate failed to meet the main goal of a mid-stage trial and would not be taken forward to a late-stage trial.
GSK Meets Study Goal for Co-Administered RSV-Shingles Vaccines
GSK
plc
GSK
announced positive topline results from a phase III study evaluating the co-administration of its two marketed
vaccines
— RSV
vaccine
Arexvy and shingles
vaccine
Shingrix — in ...
GSK Reports Positive Data From Co-administration Of RSV And Shingles Vaccines
GSK plc (GSK, GSK.L) announced positive topline data from the phase 3 trial in adults 50 years and older evaluating the
GSK's RSV, Shingles vaccines show on-par immune response in joint trial
Sept 18 (Reuters) - British drugmaker
GSK
(
GSK
.L), opens new tab said on Wednesday administration of its respiratory syncytial virus (RSV)
vaccine
and shingles shot together generated the same ...
GSK posts late-stage trial win for co-administered RSV and shingles vaccines
GSK (NYSE:GSK) announced Wednesday that its Arexvy vaccine for respiratory syncytial virus (RSV) and its Shingrix vaccine for shingles reached the main goal in a Phase 3 trial when they were co-administered in adults aged 50 and older.
FierceBiotech
10d
GSK surrenders HSV vaccine hopes after phase 2 fail, ceding race to Moderna, BioNTech
GSK’s attempt to develop the first vaccine for herpes simplex virus (HSV) has ended in failure, leaving the race open for the ...
1d
GlaxoSmithKline Sell Rating Justified by Earnings Concerns and Market Challenges
Bank of America Securities analyst Graham Parry maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) yesterday and set a ...
3d
GSK (LSE:GSK) Poised for Growth with Strong Sales, Strategic Alliances, and New Vaccine Launches
GSK(LSE:GSK) is navigating a dynamic environment marked by both opportunities and challenges. Recent highlights include a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
Secret Service admits failure
Actress Crosby dies at 90
Released after guilty plea
Suns broadcaster dies
Ga. suspect's mom indicted
Sesame Place suit verdict
J&J unit files for bankruptcy
To skip Al Smith dinner
Feds subpoena Schaeffer
TN abortion law blocked
CAH sues for trespassing
Bill to boost security OK'd
Hand count approved in GA
In-person voting begins
Rejects CNN debate invite
Top Hezbollah leader killed?
Beirut strike death toll
ISR strike on Gaza school
CA bill to protect kids online
Biden hosts 'Quad' summit
Sues pharmacy middlemen
Pandas leaving for China
House repeals emission rules
Drug price challenge revived
144K+ Mavericks recalled
FDA approves flu vaccine
1st rabies outbreak in seals
WI high court to decide
Boeing defense chief exits
SC 1st execution in 13 years
Hiker injured in bear attack
Feedback